(Q34135774)

31 July 2017

1 reference

title

Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern (English)

1 reference

acute generalized exanthematous pustulosis

31 July 2017

main subject

0 references

author name string

Sidoroff A

1

1 reference

31 July 2017

Halevy S

2

1 reference

31 July 2017

Bavinck JN

3

1 reference

31 July 2017

Vaillant L

4

1 reference

31 July 2017

Roujeau JC

5

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Journal of Cutaneous Pathology

31 July 2017

published in

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

113-119

1 reference

Acute generalized exanthematous pustulosis. Analysis of 63 cases

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematic pustulosis: a case with a lymphoma-like presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Pustular vasculitis of the hands

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Toxic pustuloderma: a self-limiting eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Pustular dermatosis induced by co-trimoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Drug-induced toxic pustuloderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis, induced by nystatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis induced by nifuroxazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Allopurinol-induced toxic pustuloderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Diltiazem-induced acute generalised exanthematous pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Toxic pustuloderma associated with clemastine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis induced by dexamethasone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis induced by paracetamol. A case with severe hemodynamic disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis induced by salazosulfapyridine in a patient with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

Acute generalized exanthematous pustulosis induced by terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

GENERALIZED PUSTULAR PSORIASIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Generalised pustular drug rash.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustular drug eruptions: a histopathological spectrum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Human parvovirus B19-induced vesiculopustular skin eruption

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Generalized pustular drug eruptions: confirmation by in vitro tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

A localized, recurrent pustular eruption following amoxycillin administration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis (AGEP): manifestation of drug allergy to propicillin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Toxic pustuloderma associated with azithromycin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustular eruptions following administration of cefazolin: a possible interaction with methyldopa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Generalized eruptive pustular drug rash due to cephalexin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustular eruption following administration of cefazolin: a second case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematic pustulosis induced by cefaclor and acetazolamide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis due to doxycycline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Chloramphenicol induced acute generalized exanthematous pustulosis proved by patch test and systemic provocation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Generalized exanthematous pustulosis induced by medications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Generalized pustular dermatosis caused by isoniazid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis induced by metronidazole: the role of patch testing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Itraconazole-induced acute generalized exanthemic pustulosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis induced by itraconazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Terbinafine-induced acute generalized exanthematous pustulosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustular psoriasis associated with hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis induced by hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Allopurinol-induced toxic pustuloderma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis induced by amoxapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustular dermatitis induced by diltiazem

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis due to diltiazem: confirmation by patch testing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Toxic pustuloderma following carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis in patients receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis induced by chromium picolinate

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Enalapril-induced toxic pustuloderma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute contact dermatitis and exanthematous pustulosis due to mercury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute generalized exanthematous pustulosis associated with paracetamol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Toxic pustuloderma induced by intracavernous prostaglandin E1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Acute exanthematous pustular dermatitis after pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Thalidomide-induced toxic pustuloderma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustuloderma during cutaneous lupus treatment with thalidomide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Pustular reactions to hexafluorosilicate in foam rubber

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

Toxic pustuloderma due to PUVA treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2001.028003113.X

7 January 2021

10.1034/J.1600-0560.2001.028003113.X

Identifiers

DOI

1 reference

31 July 2017

1 reference